pGL3 3'UTR reporter WT 1.3 kb CD274 Hs 3'UTR Final Citations (2)

Originally described in: Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
Coelho MA, de Carne Trecesson S, Rana S, Zecchin D, Moore C, Molina-Arcas M, East P, Spencer-Dene B, Nye E, Barnouin K, Snijders AP, Lai WS, Blackshear PJ, Downward J Immunity. 2017 Dec 19;47(6):1083-1099.e6. doi: 10.1016/j.immuni.2017.11.016. Epub 2017 Dec 12. PubMed Journal

---

Articles Citing pGL3 3'UTR reporter WT 1.3 kb CD274 Hs 3'UTR Final

Articles
PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR. Ghosh S, Nataraj NB, Noronha A, Patkar S, Sekar A, Mukherjee S, Winograd-Katz S, Kramarski L, Verma A, Lindzen M, Garcia DD, Green J, Eisenberg G, Gil-Henn H, Basu A, Lender Y, Weiss S, Oren M, Lotem M, Geiger B, Ruppin E, Yarden Y. Cell Rep. 2021 May 25;35(8):109181. doi: 10.1016/j.celrep.2021.109181. PubMed
Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies. Mohanty A, Afkhami M, Reyes A, Pharaon R, Yin H, Li H, Do D, Bell D, Nam A, Chang S, Gernon T, Kang R, Amini A, Sampath S, Kulkarni P, Pillai R, Villaflor V, Salgia R, Maghami E, Massarelli E. J Immunother Cancer. 2024 Jul 29;12(7):e008505. doi: 10.1136/jitc-2023-008505. PubMed

If you have published an article using this material, please email us at to have your article added to this page.